Skip to search boxSkip to navigationSkip to main content

The 21- and 23-kD forms of TCRζ are generated by specific ITAM phosphorylations

  • Nicolai S.C. Van Oers(corresponding author)
    ,
  • Brett Tohlen
    ,
  • Bernard Malissen
    ,
  • Carolyn R. Moomaw
    ,
  • Steve Afendis
    ,
*Corresponding author for this work
  • University of Texas Southwestern Medical Center
    ,
  • Institut national de la santé et de la recherche médicale
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

The T cell receptor (TCR) ζ subunit contains three immunoreceptor tyrosine-based activation motifs (ITAMs) that translate effective extracellular ligand binding into intracellular signals by becoming phosphorylated into 21- and 23-kD forms. We report here that the 21-kD form of TCRζ is generated by phosphorylation of the tyrosines in the second and third ITAMs, whereas the 23-kD form is formed by the additional phosphorylation of the membrane-proximal ITAM tyrosines. The stable formation of the 21- and 23-kD species requires the binding of the tandem SH2 domains of ZAP-70. We also report that TCR-mediated signaling processes can proceed independently of either the 21- or 23-kD species of TCRζ.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 322-328 (7 pages)

Journal (Volume, Issue Number)

Nature Immunology (Volume 1, Issue 4)

Publication milestones

  • Published - 10/2000

Publication status

Published - 10/2000

ISSN

1529-2908

Publication IDs

  • Scopus: 0034305516
  • PubMed: 11017104

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
1.64
SciVal
Author count
6
SciVal
citations
78
SciVal
Paper percentile
90
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
35
Citation count
84

Funding Details

Acknowledgments We thank J. Ritter for generation of mice; ˙H. Nikaidoh and staff from the Children’s Medical Center of Dallas;A.Weiss, D. Kioussis and M. Cobb for discussions; D. Kioussis for VA-CD2 transgenic constructs.This work was supported in part by a grant from the NIH (RO1 AI42953 to N. S. C.V. O.) and the Howard Hughes Medical Institute (C.A. S).